Want to see RXRX full AI Analyst Report?
Recursion Pharmaceuticals (RXRX) Revenue
4,711 Followers
Recursion Pharmaceuticals Revenue
Recursion Pharmaceuticals had a revenue of 18.55M in the quarter ending Sep 30, 2026, with 141.88%. This bring the company's revenue in the last twelve months to 68.23M, Increased 24.39%. In the fiscal year ending Dec 31, 2025, Recursion Pharmaceuticals had annual revenue of 74.68M with 26.92% growth.
- Revenue (ttm)
- 68.23M
- Revenue Growth
- 56.18%
- P/S Ratio
- 32.39
- Revenue/Employee
- $124,468
- Employees
- 600
- Market Cap
- $2.42B
Revenue Chart
Recursion Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 74.68M | 15.84M | 26.92% |
| Dec 31, 2024 | 58.84M | 14.96M | 34.10% |
| Dec 31, 2023 | 43.88M | 4.20M | 10.57% |
| Dec 31, 2022 | 39.68M | 29.68M | 296.81% |
| Dec 31, 2021 | 10.00M | 6.59M | 193.00% |
| Dec 31, 2020 | 3.41M | 1.70M | 99.47% |
| Dec 31, 2019 | 1.71M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.